Clinical trials recruiting in Upper Hutt, New Zealand
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 5Phase 2 3Phase 3 1
Conditions recruiting in Upper Hutt, New Zealand
Recruiting trials in Upper Hutt, New Zealand
- A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
- A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
- Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
- Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
- Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
- Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Common questions
How many clinical trials are recruiting in Upper Hutt, New Zealand?
8 recruiting trials have at least one study site in Upper Hutt, New Zealand.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.